{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T20:00:18Z","timestamp":1769889618316,"version":"3.49.0"},"reference-count":68,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.1536\/ihj.24-706","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:09:27Z","timestamp":1769810967000},"page":"65-76","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Role and Mechanism of DSF in HFpEF Based on IL-1\u03b2\/IL-1\u03b2R\/TAK1\/RIPK1 Axis-Mediated PANoptosis"],"prefix":"10.1536","volume":"67","author":[{"given":"Weidong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"},{"name":"Science and Technology Innovation Center of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"},{"name":"Science and Technology Innovation Center of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Emergency, Affiliated Hospital of North Sichuan Medical College"},{"name":"Science and Technology Innovation Center of North Sichuan Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","unstructured":"1. Tsao CW, Aday AW, Almarzooq ZI, <i>et al<\/i>. Heart disease and stroke Statistics-2022 update: a report from the American Heart Association. Circulation 2022; 145: e153-639."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study. Lancet 2018; 392: 1789-858.","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020; 22: 1342-56.","DOI":"10.1002\/ejhf.1858"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res 2019; 124: 1598-617.","DOI":"10.1161\/CIRCRESAHA.119.313572"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res 2021; 128: 1421-34.","DOI":"10.1161\/CIRCRESAHA.121.318172"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tsao CW, Lyass A, Enserro D, <i>et al<\/i>. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail 2018; 6: 678-85.","DOI":"10.1016\/j.jchf.2018.03.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li C, Qin D, Hu J, Yang Y, Hu D, Yu B. Inflamed adipose tissue: a culprit underlying obesity and heart failure with preserved ejection fraction. Front Immunol 2022; 13: 947147.","DOI":"10.3389\/fimmu.2022.947147"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shah KS, Xu H, Matsouaka RA, <i>et al<\/i>. Heart failure with preserved, borderline, and reduced ejection fraction 5-year outcomes. J Am Coll Cardiol 2017; 70: 2476-86.","DOI":"10.1016\/j.jacc.2017.08.074"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Borlaug BA. Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 2020; 17: 559-73.","DOI":"10.1038\/s41569-020-0363-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McDonagh TA, Metra M, Adamo M, <i>et al<\/i>. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022; 24: 4-131.","DOI":"10.1002\/ejhf.2333"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kumar P, Lim A, Poh SL, <i>et al<\/i>. Pro-inflammatory derangement of the immuno-interactome in heart failure. Front Immunol 2022; 13: 817514.","DOI":"10.3389\/fimmu.2022.817514"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ace\u00f1a \u00c1, Pello-L\u00e1zaro AM, Mart\u00ednez-Milla J, <i>et al<\/i>. Impacto de la funci\u00f3n renal en el valor pron\u00f3stico del metabolismo mineral en pacientes con cardiopat\u00eda isqu\u00e9mica cr\u00f3nica. Clin Investig Arterioscler 2021; 34: 1-9.","DOI":"10.1016\/j.arteri.2021.09.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hu JJ, Xing L, Xia S, <i>et al<\/i>. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol 2020; 21: 736-45.","DOI":"10.1038\/s41590-020-0669-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chen Y, Du J, Zheng L, <i>et al<\/i>. Chemical screening links disulfiram with cardiac protection after ischemic injury. Cell Regen 2023; 12: 25-36.","DOI":"10.1186\/s13619-023-00170-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wei S, Xiao Z, Huang J, Peng Z, Zhang B, Li W. Disulfiram inhibits oxidative stress and NLRP3 inflammasome activation to prevent LPS-induced cardiac injury. Int Immunopharmacol 2022; 105: 108545.","DOI":"10.1016\/j.intimp.2022.108545"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I\u03baB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999; 398: 252-6.","DOI":"10.1038\/18465"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Malireddi RKS, Gurung P, Mavuluri J, <i>et al<\/i>. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. J Exp Med 2018; 215: 1023-34.","DOI":"10.1084\/jem.20171922"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Malireddi RS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol 2019; 9: 406.","DOI":"10.3389\/fcimb.2019.00406"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Malireddi RS, Gurung P, Kesavardhana S, <i>et al<\/i>. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med 2020; 217: e20191644.","DOI":"10.1084\/jem.20191644"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gonzalez A, Fortu\u00f1o MA, Querejeta R, <i>et al<\/i>. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 2003; 59: 549-62.","DOI":"10.1016\/S0008-6363(03)00498-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Li W, Chen M, Xu L, <i>et al<\/i>. Morroniside alleviates coxsackievirus B3-induced myocardial damage apoptosis via restraining NLRP3 inflammasome activation. RSC Adv 2019; 9: 1222-9.","DOI":"10.1039\/C8RA08662A"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Li L, Chen Y, Doan J, Murray J, Molkentin JD, Liu Q. Transforming growth factor \u03b2-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation 2014; 130: 2162-72.","DOI":"10.1161\/CIRCULATIONAHA.114.011195"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Liu H, Huang Y, Zhao Y, <i>et al<\/i>. Inflammatory macrophage interleukin-1\u03b2 mediates high-fat diet-induced heart failure with preserved ejection fraction. JACC Basic Transl Sci 2023; 8: 174-85.","DOI":"10.1016\/j.jacbts.2022.08.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chen S, Lu Z. Macrophage NLRP3-dependent IL-1\u03b2 production contributes to aortic fibrosis in heart failure with preserved ejection fraction. Acta Biochim Biophys Sin (Shanghai) 2024; 57: 1175-83.","DOI":"10.3724\/abbs.2024238"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Srinivas BK, Bourdi A, O&apos;Regan JD, <i>et al<\/i>. Interleukin-1\u03b2 disruption protects male mice from heart failure with preserved ejection fraction pathogenesis. J Am Heart Assoc 2023; 12: e029668.","DOI":"10.1161\/JAHA.122.029668"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dunne A, O&apos;Neill LA. The interleukin-1 receptor\/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003; 2003: re3.","DOI":"10.1126\/scisignal.1712003re3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tian Y, Zhang Y, Zhong B, <i>et al<\/i>. RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-\u03baB activation by targeting TAB2\/3 for degradation. Biol Chem 2007; 282: 16776-82.","DOI":"10.1074\/jbc.M701913200"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Caoz H, Gaox IRAK. A kinase associated with the interleukin-1 receptor. Science 1996; 271: 1128-31.","DOI":"10.1126\/science.271.5252.1128"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Carpenter S, O&apos;Neill LA. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 2009; 422: 1-10.","DOI":"10.1042\/BJ20090616"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Kenny EF, O&apos;Neill LAJ. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008; 43: 342-9.","DOI":"10.1016\/j.cyto.2008.07.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-\u03baB: variations on a common theme. Cell Mol Life Sci 2008; 65: 2964-78.","DOI":"10.1007\/s00018-008-8064-8"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Deng L, Wang C, Spencer E, <i>et al<\/i>. Activation of the I\u03baB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000; 103: 351-61.","DOI":"10.1016\/S0092-8674(00)00126-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wu ZH, Wong ET, Shi Y, <i>et al<\/i>. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell 2010; 40: 75-86.","DOI":"10.1016\/j.molcel.2010.09.010"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Xia ZP, Sun L, Chen X, <i>et al<\/i>. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009; 461: 114-9.","DOI":"10.1038\/nature08247"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yu Y, Ge N, Xie M, <i>et al<\/i>. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NF-\u03baB and AP-1 activation as well as IL-6 gene expression. Biol Chem 2008; 283: 24497-505.","DOI":"10.1074\/jbc.M802825200"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Wang C, Deng L, Hong M, Akkaraju GR, Inoue JI, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346-51.","DOI":"10.1038\/35085597"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yamazaki K, Gohda J, Kanayama A, <i>et al<\/i>. Two mechanistically and temporally distinct NF-\u03baB activation pathways in IL-1 signaling. Sci Signal 2009; 2: ra66.","DOI":"10.1126\/scisignal.2000387"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Chen ZJ. Ubiquitin signalling in the NF-\u03baB pathway. Nat Cell Biol 2005; 7: 758-65.","DOI":"10.1038\/ncb0805-758"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Schiattarella GG, Altamirano F, Tong D, <i>et al<\/i>. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 2019; 568: 351-6.","DOI":"10.1038\/s41586-019-1100-z"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Abudureyimu M, Luo X, Jiang L, <i>et al<\/i>. FBXL4 protects against HFpEF through Drp1-mediated regulation of mitochondrial dynamics and the downstream SERCA2a. Redox Biol 2024; 70: 103081.","DOI":"10.1016\/j.redox.2024.103081"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Galderisi M, Cosyns B, Edvardsen T, <i>et al<\/i>. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2017; 18: 1301-10.","DOI":"10.1093\/ehjci\/jex244"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Meng L, Lu Y, Wang X, <i>et al<\/i>. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA\/PKG and inhibiting TGF-\u03b21\/Smad pathways. Sci Adv 2023; 9: eadd4222.","DOI":"10.1126\/sciadv.add4222"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.","DOI":"10.1038\/nri3452"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Fuller RK, Branchey L, Brightwell DR, <i>et al<\/i>. Disulfiram treatment of alcoholism. A veterans administration cooperative study. JAMA 1986; 256: 1449-55.","DOI":"10.1001\/jama.256.11.1449"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Sonawane VK, Mahajan UB, Shinde SD, <i>et al<\/i>. A chemosensitizer drug: disulfiram prevents doxorubicin-induced cardiac dysfunction and oxidative stress in rats. Cardiovasc Toxicol 2018; 18: 459-70.","DOI":"10.1007\/s12012-018-9458-y"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Pieske B, Tsch\u00f6pe C, de Boer RA, <i>et al<\/i>. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal 2019; 40: 3297-317.","DOI":"10.1093\/eurheartj\/ehz641"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2021; 18: 400-23.","DOI":"10.1038\/s41569-020-00480-6"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013; 62: 263-71.","DOI":"10.1016\/j.jacc.2013.02.092"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Shah SJ, Kitzman DW, Borlaug BA, <i>et al<\/i>. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 2016; 134: 73-90.","DOI":"10.1161\/CIRCULATIONAHA.116.021884"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2303-12.","DOI":"10.1172\/JCI116834"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Haudek SB, Taffet GE, Schneider MD, Mann DL. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J ClinInvest 2007; 117: 2692-701.","DOI":"10.1172\/JCI29134"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Hamid T, Gu Y, Ortines RV, <i>et al<\/i>. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-\u03baB and inflammatory activation. Circulation 2009; 119: 1386-97.","DOI":"10.1161\/CIRCULATIONAHA.108.802918"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 2021; 597: 415-9.","DOI":"10.1038\/s41586-021-03875-8"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy. Pharmacol Ther 2022; 232: 108010.","DOI":"10.1016\/j.pharmthera.2021.108010"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Malireddi RKS, Kesavardhana S, Karki R, Kancharana B, Burton AR, Kanneganti TD. RIPK1 distinctly regulates Yersinia-induced inflammatory cell death, PANoptosis. Immunohorizons 2020; 4: 789-96.","DOI":"10.4049\/immunohorizons.2000097"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Li CY, Zhou Q, Yang LC, <i>et al<\/i>. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK\/-JNK1\/2 signaling pathway. Basic Res Cardiol 2016; 111: 19.","DOI":"10.1007\/s00395-016-0536-7"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev 2019; 99: 1765-817.","DOI":"10.1152\/physrev.00022.2018"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Chen Y, He Y, Wei X, Jiang DS. Targeting regulated cell death in aortic aneurysm and dissection therapy. Pharmacol Res 2022; 176: 106048.","DOI":"10.1016\/j.phrs.2021.106048"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Li M, Wang ZW, Fang LJ, Cheng SQ, Wang X, Liu NF. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis 2022; 13: 467.","DOI":"10.1038\/s41419-022-04923-5"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Fang ZM, Feng X, Chen Y, Luo H, Jiang DS, Yi X. Targeting autophagy in aortic aneurysm and dissection. Biomed Pharmacother 2022; 153: 113547.","DOI":"10.1016\/j.biopha.2022.113547"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Li J, Zhang X, Ren P, <i>et al<\/i>. Landscape of RNA-binding proteins in diagnostic utility, immune cell infiltration and PANoptosis features of heart failure. Front Genet 2022; 13: 1004163.","DOI":"10.3389\/fgene.2022.1004163"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Chen H, Xie X, Xiao H, <i>et al<\/i>. A pilot study about the role of PANoptosis-based genes in atherosclerosis development. J Inflam Res 2023; 16: 6283-99.","DOI":"10.2147\/JIR.S442260"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Bi Y, Xu H, Wang X, <i>et al<\/i>. FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM. Cell Death Dis 2022; 13: 1020.","DOI":"10.1038\/s41419-022-05460-x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Yuey M, Puy Z. Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract 2017; 133: 124-30.","DOI":"10.1016\/j.diabres.2017.08.018"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Karki R, Lee S, Mall R, <i>et al<\/i>. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol 2022; 7: eabo6294.","DOI":"10.1126\/sciimmunol.abo6294"},{"key":"66","doi-asserted-by":"publisher","unstructured":"66. Luo W, Wang Y, Zhang L, <i>et al<\/i>. Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture. Circulation 2020; 141: 42-66.","DOI":"10.1161\/CIRCULATIONAHA.119.041460"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Li N, Zhou H, Wu H, <i>et al<\/i>. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol 2019; 24: 101215.","DOI":"10.1016\/j.redox.2019.101215"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Lei Y, VanPortfliet JJ, Chen YF, <i>et al<\/i>. Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity. Cell 2023; 186: 3013-32.e22.","DOI":"10.1016\/j.cell.2023.05.039"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/1\/67_24-706\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:12:03Z","timestamp":1769832723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/1\/67_24-706\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-706","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"article-number":"24-706"}}